Gi-Young Sohn
Chief Executive Officer at ENZYCHEM LIFESCIENCES CORPORATION
Net worth: 6 M $ as of 29/04/2024
Profile
Gi-Young Sohn is currently the Chief Executive Officer & Director at ENZYCHEM LIFESCIENCES Corp.
since 2012.
He is also the Chairman at Bridget Lifesciences Corp.
since 2003.
Mr. Sohn has an undergraduate and graduate degree from Korea University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 06/05/2024 | 4,069,430 ( 4.78% ) | 6 M $ | 29/04/2024 |
Gi-Young Sohn active positions
| Companies | Position | Start |
|---|---|---|
| ENZYCHEM LIFESCIENCES CORPORATION | Chief Executive Officer | 31/05/2012 |
Bridget Lifesciences Corp.
 Bridget Lifesciences Corp. Financial ConglomeratesFinance Bridget Lifesciences Corp. functions as an investment holding South Korean company. Hye-Kyung Kim has been the CEO of the private company since 2003. | Chairman | 31/12/2002 |
Training of Gi-Young Sohn
| Korea University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ENZYCHEM LIFESCIENCES CORPORATION | Health Technology |
| Private companies | 1 |
|---|---|
Bridget Lifesciences Corp.
Bridget Lifesciences Corp. Financial ConglomeratesFinance Bridget Lifesciences Corp. functions as an investment holding South Korean company. Hye-Kyung Kim has been the CEO of the private company since 2003. | Finance |
- Stock Market
- Insiders
- Gi-Young Sohn
